SPENCER JOHNSON: Open Payments
NPI 1528570116 · SAN DIEGO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,160 in 99 payments from 18 companies in 2025. Trend: 2023 $1,157 · 2024 $2,548 · 2025 $2,160
Food & beverage: $2,160
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 24 | $440 |
| Janssen Biotech, Inc. | 14 | $301 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $271 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 8 | $176 |
| GENZYME CORPORATION | 4 | $164 |
| PFIZER INC. | 9 | $159 |
| Regeneron Healthcare Solutions, Inc. | 4 | $104 |
| Ardelyx, Inc. | 4 | $84 |
| Celltrion USA Inc. | 4 | $78 |
| Lilly USA, LLC | 3 | $77 |
Products named: TREMFYA, ENTYVIO, DUPIXENT, RINVOQ, XIFAXAN, LINZESS, VELSIPITY, IBSRELA.
Industry payments across CA — which companies pay providers there.
